Terbisan Topical 75mg
Risk Factors:
Pregnancy/Lactation: Distributed in breast milk. Children: Safety and efficacynot esTabletlished in children younger than 4 yrs of age. Elderly: Age-related renalimpairment may require dosage adjustment.Contraindications: Hypersensitivity to terbinafine. Chronic or active hepaticdisease.
Indications:
Systemic: Treatment of onychomycosis (fungal disease of nails due to
dermatophytes). Treatment of tinea Capsolitis. Topical: Treatment of tinea cruris
(jock itch) tinea pedis (athlete?s foot) tinea corporis (ringworm) tinea
versicolor.
Adverse Effects:
Frequent (13%): PO: Headache. Occasional (6%?3%): PO: Abdominal pain
flatulence urticaria visual disturbance. Rare: PO: Diarrhea rash dyspepsia
pruritus altered taste nausea. Topical: Irritation burning pruritus dryness.
Adverse effects/toxic reactions
Hepatobiliary dysfunction (including cholestatic hepatitis) serious skin
reactions severe neutropenia occur rarely. Ocular lens retinal changes have been
noted.
Don’t Use:
Precautions: Lesions irritated by alcohol.